| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 16, 2011 | Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,500 | $14.14 | 28,000 | |
| Oct 20, 2011 | Director, President and CEO | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | -- | -- | 500 | |
| Oct 18, 2011 | SVP, GM - Vascular | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 20,000 | |
| Oct 18, 2011 | SVP, GM - Vascular | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | -- | 100,000 | |
| Oct 05, 2011 | President and CEO | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 200,000 | -- | 200,000 | |
| Oct 05, 2011 | President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 200,000 | -- | 400,000 | |
| Sep 07, 2011 | President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- | 25,000 | |
| Sep 07, 2011 | President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 400,000 | -- | 400,000 | |
| Sep 06, 2011 | EVP - CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,000 | $13.49 | 39,619 | |
| Sep 06, 2011 | EVP - CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,086 | $13.49 | 38,533 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.